Nov 06, 2019 / 08:10PM GMT
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity Research
All right. We're going to go ahead and begin. You want to make sure that microphone -- we'll see. Maybe it's fine. Sometimes (inaudible) in this room. So happy to be here with Bristol-Myers. Well, I'm Tim Anderson, the pharma analyst at Wolfe. We have Giovanni Caforio, who's the CEO and Chairman of the Board. He's been with the company since 2000 and prior to that his 12 years at Abbott Labs. He's also the current Chairman of the PhRMA Board of Directors, so PhRMA being the trade organization. And you've been in that position for maybe a year?
Giovanni Caforio - Bristol-Myers Squibb Company - Chairman of the Board & CEO
Since September 1. So less than a year.
Questions and Answers:
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity ResearchOkay. So I thought we'd start off with some general questions. And a lot of these initial questions are going to be on the transaction that's pending with Celgene, as you might imagine. So let
Trustpilot
